These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 33484201)
1. Application of ischaemia-free liver transplantation improves prognosis of patients with steatotic donor livers - a retrospective study. Chen M; Chen Z; Lin X; Hong X; Ma Y; Huang C; He X; Ju W Transpl Int; 2021 Jul; 34(7):1261-1270. PubMed ID: 33484201 [TBL] [Abstract][Full Text] [Related]
2. Prospective, single-centre, randomised controlled trial to evaluate the efficacy and safety of ischaemia-free liver transplantation (IFLT) in the treatment of end-stage liver disease. Huang C; Huang S; Tang Y; Zhao Q; Wang D; Ju W; Yang L; Zhang J; Wu L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Sun C; Xiong W; Shen Y; Chen X; Ma Y; Hu A; Zhu X; Rong J; Cai C; Guo Z; He X BMJ Open; 2020 May; 10(5):e035374. PubMed ID: 32376754 [TBL] [Abstract][Full Text] [Related]
3. [The effect of steatotic donor livers on the prognosis of donors and recipients after pediatric living donor liver transplantation]. Yang Y; Dong C; Sun C; Wang K; Zhang W; Zheng WP; Zhang FB; Qin H; Han C; Wang Z; Xu M; Gao W Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):922-929. PubMed ID: 36207981 [No Abstract] [Full Text] [Related]
4. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation. Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794 [TBL] [Abstract][Full Text] [Related]
5. Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Tang Y; Wang T; Ju W; Li F; Zhang Q; Chen Z; Gong J; Zhao Q; Wang D; Chen M; Guo Z; He X Front Oncol; 2021; 11():773535. PubMed ID: 34966679 [TBL] [Abstract][Full Text] [Related]
6. Use of severely steatotic grafts in liver transplantation: a matched case-control study. McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095 [TBL] [Abstract][Full Text] [Related]
7. Ischaemia-free liver transplantation in humans: a first-in-human trial. Guo Z; Zhao Q; Huang S; Huang C; Wang D; Yang L; Zhang J; Chen M; Wu L; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Tang Y; Sun C; Xiong W; Shen Y; Chen X; Xu J; Wang T; Ma Y; Hu A; Chen Y; Zhu X; Rong J; Cai C; Gong F; Guan X; Huang W; Ko DS; Li X; Tullius SG; Huang J; Ju W; He X Lancet Reg Health West Pac; 2021 Nov; 16():100260. PubMed ID: 34590063 [TBL] [Abstract][Full Text] [Related]
8. Similar outcome after transplantation of moderate macrovesicular steatotic and nonsteatotic livers when the cold ischemia time is kept very short. Westerkamp AC; de Boer MT; van den Berg AP; Gouw AS; Porte RJ Transpl Int; 2015 Mar; 28(3):319-29. PubMed ID: 25545740 [TBL] [Abstract][Full Text] [Related]
9. Does Donor Allograft Microsteatosis Matter? Comparison of Outcomes in Liver Transplantation With a Propensity-Matched Cohort. Croome KP; Lee DD; Croome S; Nakhleh RE; Abader Sedki Senada P; Livingston D; Yataco M; Taner CB Liver Transpl; 2019 Oct; 25(10):1533-1540. PubMed ID: 31187923 [TBL] [Abstract][Full Text] [Related]
10. Excellent outcomes of liver transplantation using severely steatotic grafts from brain-dead donors. Wong TC; Fung JY; Chok KS; Cheung TT; Chan AC; Sharr WW; Dai WC; Chan SC; Lo CM Liver Transpl; 2016 Feb; 22(2):226-36. PubMed ID: 26359934 [TBL] [Abstract][Full Text] [Related]
11. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646 [TBL] [Abstract][Full Text] [Related]
12. Non-re-cooling implantation of marginal liver graft after machine perfusion: report of a case. Ju W; Chen Z; Zhao Q; Zhang Y; Huang C; Wang L; Zhu C; Chen Y; Guo Z; Chen M; He X Ann Transl Med; 2020 Nov; 8(21):1465. PubMed ID: 33313210 [TBL] [Abstract][Full Text] [Related]
13. A randomized-controlled trial of ischemia-free liver transplantation for end-stage liver disease. Guo Z; Zhao Q; Jia Z; Huang C; Wang D; Ju W; Zhang J; Yang L; Huang S; Chen M; Zhu X; Hu A; Ma Y; Wu L; Chen Y; Han M; Tang Y; Wang G; Wang L; Li L; Xiong W; Zhang Z; Shen Y; Tang Z; Zhu C; Chen X; Hu X; Guo Y; Chen H; Ma Y; Zhang T; Huang S; Zeng P; Lai S; Wang T; Chen Z; Gong J; Yu J; Sun C; Li C; Tan H; Liu Y; Dong Y; Sun C; Liao B; Ren J; Zhou Z; Andrea S; Björn N; Cai C; Gong F; Rong J; Huang W; Guan X; Clavien PA; Stefan TG; Huang J; He X J Hepatol; 2023 Aug; 79(2):394-402. PubMed ID: 37086919 [TBL] [Abstract][Full Text] [Related]
14. Abrogation of graft ischemia-reperfusion injury in ischemia-free liver transplantation. Guo Z; Xu J; Huang S; Yin M; Zhao Q; Ju W; Wang D; Gao N; Huang C; Yang L; Chen M; Zhang Z; Zhu Z; Wang L; Zhu C; Zhang Y; Tang Y; Chen H; Liu K; Lu Y; Ma Y; Hu A; Chen Y; Zhu X; He X Clin Transl Med; 2022 Apr; 12(4):e546. PubMed ID: 35474299 [TBL] [Abstract][Full Text] [Related]
15. Steatotic livers. Can we use them in OLTX? Outcome data from a prospective baseline liver biopsy study. Gabrielli M; Moisan F; Vidal M; Duarte I; Jiménez M; Izquierdo G; Domínguez P; Méndez J; Soza A; Benitez C; Pérez R; Arrese M; Guerra J; Jarufe N; Martínez J Ann Hepatol; 2012; 11(6):891-8. PubMed ID: 23109453 [TBL] [Abstract][Full Text] [Related]
16. Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation. Andert A; Ulmer TF; Schöning W; Kroy D; Hein M; Alizai PH; Heidenhain C; Neumann U; Schmeding M Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):617-623. PubMed ID: 29291781 [TBL] [Abstract][Full Text] [Related]
17. Overcoming the hurdles of steatotic grafts in liver transplantation: Insights into survival and prognostic factors. Akabane M; Imaoka Y; Esquivel CO; Melcher ML; Kwong A; Sasaki K Liver Transpl; 2024 Apr; 30(4):376-385. PubMed ID: 37616509 [TBL] [Abstract][Full Text] [Related]
18. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation. Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model. Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831 [TBL] [Abstract][Full Text] [Related]
20. Extended-criteria donors in liver transplantation Part II: reviewing the impact of extended-criteria donors on the complications and outcomes of liver transplantation. Nemes B; Gámán G; Polak WG; Gelley F; Hara T; Ono S; Baimakhanov Z; Piros L; Eguchi S Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):841-59. PubMed ID: 26831547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]